EU Osteoporosis Market Analysis


  • Type: Common Disease Area
  • Published : January 2022
  • Region: Europe
  • Country: Other
  • Report ID : 5010

  • Format: PPT, PDF

EU Osteoporosis Market Analysis: Segmented by Route of Administration, Drug class, Country – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

SKU: 5010 Categories: ,

Report Description of the EU Osteoporosis Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for EU Osteoporosis Market Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the EU Osteoporosis Market Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

EU Osteoporosis Market Analysis Executive Summary

Osteoporosis is a complex, chronic disease that can be treated and managed in a number of ways. Improvements in medication and diagnostic techniques in the past 30 years have provided highly effective ways to reduce the risk of osteoporotic fractures. In Europe, however, research has shown significant heterogeneity in the different national approaches to the management of the disease.

Market Size and Key Findings

The EU Osteoporosis Market Analysis size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 4% during the forecast period.

Market Dynamics

Market Growth Drivers Analysis

Rank ligand inhibitors may also be used in conjunction with other drugs to give a synergistic effect on the overall treatment regimen. It is also anticipated that this factor will be one of the key factors responsible for presenting lucrative opportunities. Other advantages related to ligand rank Inhibitors such as decreased bone cell turnover and increased bone mineral density, resulting in high demand. The major factor contributing to the growth of the market for osteoporosis drugs is the increase in the prevalence of osteoporosis. In addition, other reasons that fuel the growth of the osteoporosis drugs market are the rise for the geriatric population worldwide and the rise in sedentary lifestyles worldwide. However, the adverse effects of osteoporosis medications and the time-consuming medication development procedure impede the expansion of the demand for osteoporosis medicines. Conversely, strong growth potential in developed economies is projected to generate attractive prospects over the forecast period.

Market Restraints

Growth in the market for osteoporosis drugs is likely to be delayed due to side effects and risks involved with osteoporosis medications. For e.g., heartburn, muscle and joint pain, diarrhea, and stomach or esophagus ulcers are risks associated with the drug class of bisphosphonates. Other than this, other classes of drugs also have side effects in patients. Many risks caused by osteoporosis medications include bone trauma, bone breaks, and urinary infection. Moreover, the patent expiry of new branded products and the restricted reimbursement by healthcare payers often adversely affect the growth of the market.

COVID-19 impact on “EU Osteoporosis Market Analysis” 

EU-funded consortium Exscalate4CoV has announced that an already registered generic drug used to treat osteoporosis, Raloxifene, could be an effective treatment for COVID-19 patients with mildly symptomatic infection. The consortium is using an EU-backed supercomputing platform, one of the world’s most powerful, to check the potential impact of known molecules against the genomic structure of coronavirus. This is one of many examples of how the EU’s research and innovation programme Horizon 2020 is bringing together the best of European researchers, pharmaceutical companies, technologies and research infrastructures to contribute to defeating the virus.

Competitive Landscape

Key Players

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amgen, Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC (GSK), Merck & Co., Inc., Novartis AG, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., Allergan PLC, and Eli Lilly and Company.

Products in Pipeline

In 1994 and 2008, the WHO published diagnostic criteria for osteoporosis in postmenopausal women based on the T-score for bone mineral density (BMD). Osteoporosis is defined as a value for BMD 2.5 standard deviations (SD) or more below the young female adult mean (T-score less than or equal to −2.5 SD).

Notable Recent Deals

The scorecard for osteoporosis in Europe (SCOPE) is a project of the International Osteoporosis Foundation (IOF) that seeks to raise awareness of osteoporosis care in Europe. The aim of this project was to develop a scorecard and background documents to draw attention to gaps and inequalities in the provision of primary and secondary prevention of fractures due to osteoporosis.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

Health strategies across European countries have recognised the critical role of reducing frailty and maintaining mobility as part of healthy ageing and prevention. Yet osteoporosis does not usually appear in national prevention strategies. In policies for chronic disease, other conditions such as diabetes and heart disease have received considerably more attention from European policymakers. A recent analysis showed that musculoskeletal health, which includes osteoporosis and fragility fractures, was only included in half of non-communicable disease strategies for OECD countries. Few countries specifically address women’s needs in national health policy. In those that do, osteoporosis is often absent despite its significant impact on women’s health.

1. Report Description of the EU Osteoporosis Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. EU Osteoporosis Market Analysis Executive Summary
2.1 EU Osteoporosis Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of EU Osteoporosis Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 Increase in the prevalence of osteoporosis
3.1.2 Rise for the geriatric population
3.1.3 Expansion of the demand for osteoporosis medicines
3.2 Market Restraints Analysis
3.2.1 Risks involved with osteoporosis medications
3.2.2 The patent expiry of new branded products
3.2.3 Restricted reimbursement
3.3 Covid-19 Market Impact Analysis
4. EU Osteoporosis Market Segmentation
4.1 By Route of Administration:
4.1.1 Oral
4.1.2 Injectable and
4.1.3 Other Route of Administration
4.2 By Drug Class:
4.2.1 Bisphosphonates
4.2.2 Rank Ligand Inhibitors
4.2.3 Parathyroid Hormone Therapy
4.2.4 Calcitonin
4.2.5 Selective Estrogen Inhibitors Modulator (SERM) and
4.2.6 Other Drug Classes
4.3 By Country:
4.3.1 Germany
4.3.2 UK
4.3.3 France
4.3.4 Russia
4.3.5 Spain
4.3.6 Italy
4.3.7 Rest of Europe
5. EU Osteoporosis Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Osteoporosis Market
6.4 Notable recent deals in Osteoporosis Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Amgen, Inc. Company overview
Product & Services, Strategies & Financials
7.2 F. Hoffmann-La Roche Ltd. Company overview
Product & Services, Strategies & Financials
7.3 GlaxoSmithKline PLC (GSK) Company overview
Product & Services, Strategies & Financials
7.4 Merck & Co., Inc. Company overview
Product & Services, Strategies & Financials
7.5 Novartis AG Company overview
Product & Services, Strategies & Financials
7.6 Pfizer, Inc. Company overview
Product & Services, Strategies & Financials
7.7 Sun Pharmaceutical Industries Ltd. Company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Osteoporosis market
9.2 Future Opportunities
10. Strategic Recommendations

EU Osteoporosis Market Analysis Segmentation

By Route of Administration:

  • Oral
  • Injectable and
  • Other Route of Administration

By Drug Class:

  • Bisphosphonates
  • Rank Ligand Inhibitors
  • Parathyroid Hormone Therapy
  • Calcitonin
  • Selective Estrogen Inhibitors Modulator (SERM) and
  • Other Drug Classes

By Country:

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements